FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea
by Lori Solomon edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea. The first approval is for Nuzolvence (zoliflodacin) granules that dissolve in water and are intended to treat uncomplicated urogenital gonorrhea in adults and children ages 12 years […]
FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea Read More »
